Neuraxis, Inc. NRXS
7.56
(0.19)
(2.45%)
as of 25 Sep
- Market cap
- $97.3M
- P/E
- 0.0×
Follow NRXS
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
9.05 | 11.55 | 18.92 | 16.67 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(21.31) | (21.32) | (65.88) | (86.06) | |
P/B ratio |
13.34 | 12.14 | 14.10 | 13.16 | |
Price to Tangible BV |
15.23 | 13.21 | 14.79 | 13.69 | |
EV/Sales |
7.76 | 10.17 | 17.28 | 15.11 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(4.17) | (5.64) | (12.21) | (14.29) | |
EV/FCF |
(4.09) | (5.50) | (11.87) | (13.89) | |
Quick Ratio |
1.43 | 1.85 | 2.65 | 2.83 | |
Current Ratio |
1.58 | 2.05 | 2.89 | 3.04 | |
Net Debt/EBITDA |
2.10 | 2.93 | 4.11 | 3.95 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.97 | 0.64 | 0.73 | 0.62 | |
Operating CF/Net income |
0.61 | 1.02 | 0.63 | 0.45 | |
Capex/Depreciation |
0.00 | (4.39) | 0.00 | (0.38) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.13% | 13.40% | 6.19% | 14.22% | |
Selling, General and Administrative Expense of Revenue |
326.00% | 249.35% | 188.48% | 181.81% | |
Intangible Assets out of Total Assets |
0.05 | 0.04 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
19.82% | 16.24% | 20.49% | 33.17% | |
Graham Net Nets |
0.05 | 0.07 | 0.06 | 0.07 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(31.82%) | (20.70%) | (10.95%) | (10.67%) | |
Free Cash Flow Yield |
(20.95%) | (16.02%) | (7.69%) | (6.53%) | |
Revenue per Share |
0.08 | 0.11 | 0.15 | 0.16 | |
Operating CF per Share |
(0.14) | (0.21) | (0.11) | (0.08) | |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.14) | (0.22) | (0.11) | (0.09) | |
Cash per Share |
0.44 | 0.55 | 0.65 | 0.69 | |
Shareholders Equity per Share |
0.23 | 0.37 | 0.53 | 0.56 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.23 | 0.37 | 0.53 | 0.56 | |
Free Cash Flow |
(1.43) | (2.04) | (1.23) | (1.04) | |
Working Capital |
1.84 | 2.94 | 5.33 | 6.32 | |
Capital Expenditures |
0.00 | (0.11) | — | (0.01) | |
Net Current Asset Value |
1.50 | 2.73 | 5.14 | 6.15 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.11 | 0.00 | 0.00 | |
Net Profit Margin |
(286.11%) | (196.62%) | (121.33%) | (118.07%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.08 | 0.22 | 0.31 | 0.28 | |
Average Payables |
0.92 | 0.37 | 0.42 | 0.63 | |
Average Inventory |
0.07 | 0.15 | 0.14 | 0.20 | |
Average Assets |
3.46 | 5.58 | 5.89 | 8.54 | |
Average Common Equity |
0.24 | 2.73 | 3.00 | 5.49 |
Columns are period end dates